3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Prostatic Neoplasms
13
Neoplasms
8
Breast Neoplasms
4
Hypogonadism
3
Testicular Neoplasms
2
Polycystic Ovary Syndrome
2
Fatigue
2
Dyspareunia
2
Arthralgia
2
Vaginitis
1
Sleep Apnea, Obstructive
1
Sleep Apnea Syndromes
1
Sexuality
1
Sexual Dysfunction, Physiological
1
Osteoporosis
1
Obesity
1
Neoplasm Metastasis
1
Muscle Weakness
1
Multiple Endocrine Neoplasia Type 1
1
Motor Activity
1
Metabolic Syndrome
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Infertility
1
Hot Flashes
1
Eunuchism
1
Carcinoma, Intraductal, Noninfiltrating
1
Breast Neoplasms, Male
1
Interventions
Zoledronic Acid
16
Risedronic Acid
9
Vitamin D
8
Calcium
8
Letrozole
6
Cholecalciferol
5
Calcium Carbonate
5
Alendronate
5
Denosumab
4
Absorptiometry, Photon
4
Calcium Gluconate
3
parathyroid hormone-related peptide (1-36)
2
bicalutamide
2
Resistance Training
2
Progesterone
2
Nutrition Assessment
2
Kyphoplasty
2
Hormone Replacement Therapy
2
Goserelin
2
Estradiol
2
Calcium Citrate
2
xian ling gu bao
1
romosozumab
1
X-Rays
1
Toremifene
1
Testosterone
1
Technetium
1
Spectrum Analysis
1
Raloxifene Hydrochloride
1
Radiotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Osteoporosis
×
Testosterone
×
Clear all
NCT00497458
2009-04-09
ART2
Havah Therapeutics Pty Ltd
Phase 2
Unknown
90 enrolled